KFU. Card publication. Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

PHARMACOEPIDEMIOLOGY OF ANTIEPILEPTIC DRUGS IN CHILDREN: COMPARATIVE ANALYSIS OF EFFICACY AND SAFETY

Form of presentation

Articles in Russian journals and collections

Year of publication

2012

��

��

Authors, employees of KFU

Ziganshina Liliya Evgenevna, author

Bibliographic description in the original language

Gamirova R.G. Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety / R.M. Shaimardanovaa and L.E. Ziganshinab // International Journal of Risk & Safety in Medicine/ - 2012. - � 24. - C. 179-185

Annotation

Pharmacoepidemiology analysis of efficacy and safety of antiepileptics was carried out in children (3 months?18 years old) registered with municipal children?s epilepsy services: 548 children in 2005, 718 ? In 2007 and 32 ? In 2011. We used remission lasting for 1 year or longer, and 3 years or longer as primary effectiveness outcomes, and total number of people with adverse effects as a safety outcome. We found no advantages of newer antiepileptics over the older ones in terms of either efficacy or safety. Long-term follow up (more than 3 years) showed higher treatment response rate in patients with childhood versus juvenile absence epilepsy.

Keywords

pharmacoepidemiology of antiepileptics, efficacy, safety

The name of the journal

International Journal of Risk & Safety in Medicine

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=127583&p_lang=2

Resource files

File name	Size (MB)	Format
antiepileptic_drugs.pdf	0,05	pdf	show / download

Full metadata record

Field DC	Value	Language
dc.contributor.author	Ziganshina Liliya Evgenevna	ru_RU
dc.date.accessioned	2012-01-01T00:00:00Z	ru_RU
dc.date.available	2012-01-01T00:00:00Z	ru_RU
dc.date.issued	2012	ru_RU
dc.identifier.citation	Gamirova R.G. Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety / R.M. Shaimardanovaa and L.E. Ziganshinab // International Journal of Risk & Safety in Medicine/ - 2012. - � 24. - C. 179-185	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=127583&p_lang=2	ru_RU
dc.description.abstract	International Journal of Risk & Safety in Medicine	ru_RU
dc.description.abstract	Pharmacoepidemiology analysis of efficacy and safety of antiepileptics was carried out in children (3 months?18 years old) registered with municipal children?s epilepsy services: 548 children in 2005, 718 ? In 2007 and 32 ? In 2011. We used remission lasting for 1 year or longer, and 3 years or longer as primary effectiveness outcomes, and total number of people with adverse effects as a safety outcome. We found no advantages of newer antiepileptics over the older ones in terms of either efficacy or safety. Long-term follow up (more than 3 years) showed higher treatment response rate in patients with childhood versus juvenile absence epilepsy.	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	pharmacoepidemiology of antiepileptics	ru_RU
dc.subject	efficacy	ru_RU
dc.subject	safety	ru_RU
dc.title	Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety	ru_RU
dc.type	Articles in Russian journals and collections	ru_RU